Therma Bright Inc V.THRM

INFO

[FREEDOM55]

For Immediate Release:

August 03, 2021

 

The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:

• In mid-July, the FDA held a stakeholder call to discuss COVID-19 vaccines, including preliminary reports of Guillain-Barr Syndrome following Janssen (Johnson & Johnson) COVID-19 vaccination. Acting FDA Commissioner Janet Woodcock, M.D. and the Director of FDA's Center for Biologics Evaluation and Research, Peter Marks, M.D., Ph.D. were featured speakers. The call can be found on the FDA’s YouTube pageExternal Link Disclaimer.
• Testing updates:
  • As of today, 398 tests and sample collection devices are authorized by the FDA under emergency use authorizations (EUAs). These include 279 molecular tests and sample collection devices, 87 antibody and other immune response tests and 32 antigen tests. There are 53 molecular authorizations and one antibody authorization that can be used with home-collected samples. There is one molecular prescription at-home test, three antigen prescription at-home tests, six antigen over-the-counter (OTC) at-home tests and two molecular OTC at-home tests.
  • The FDA has authorized 13 antigen tests and eight molecular tests for serial screening programs. The FDA has also authorized 595 revisions to EUA authorizations.

[stockmonster6]

only 6 OTC at home antigen tests.  Nice. Lots of room for THRM in US market share.

[Moemoney42]

Wow I didn't realize the playing field was that crowded.. scary for a new comer with no cash to compete in the market place with pricing pressures..!!

[Greenrolls8]

This post has been removed in accordance with Community Policy

[Greenrolls8]

This post has been removed in accordance with Community Policy